Impact of changing activation sequence on bipolar electrogram amplitude for voltage mapping of left ventricular infarcts causing ventricular tachycardia.
BACKGROUND
Wavefront direction is a determinant of bipolar electrogram amplitude that could influence identification of low amplitude regions indicating infarction or scar.


METHODS
To assess the importance of activation sequence on electrogram amplitude 11 patients with prior infarction and ventricular tachycardia were studied. At 819 left ventricular sites bipolar electrograms were recorded during atrial pacing and ventricular pacing, followed by unipolar pacing with a stimulus of 10 mA at 2 ms. Sites with a pacing threshold > 10 mA were designated electrically unexcitable scar.


RESULTS
Areas of low voltage (< or =1.5 mV) were present in all patients. Atrial paced and ventricular paced electrogram amplitudes were strongly correlated (r = 0.77; P < 0.0001). Changing the activation sequence (from atrial pacing to ventricular pacing) produced a > 50% change in electrogram amplitude at 28% of sites and a > 100% change at 10% of sites, but only 8% of sites had an electrogram amplitude classified as abnormal (< or =1.5 mV) with one activation sequence and normal (> 1.5 mV) with the other activation sequence. Electrically unexcitable scar (6% of sites) was associated with lower electrogram amplitude but could not be reliably identified based on electrogram amplitude alone for either activation sequence.


CONCLUSIONS
Voltage maps created with bipolar recordings using these methods should be relatively robust depictions of abnormal ventricular regions despite variable catheter orientation and activation sequences that might be produced by different rhythms.
Brunckhorst
Corinna B
CB
Cardiovascular Center, University Hospital Zurich, Switzerland. corinna.brunckhorst@usz.ch
Delacretaz
Etienne
E
Soejima
Kyoko
K
Maisel
William H
WH
Friedman
Peter L
PL
Stevenson
William G
WG
D000368:Aged; D018780:Body Surface Potential Mapping / Q000379:methods*; D006328:Cardiac Catheterization; D002304:Cardiac Pacing, Artificial / Q000379:methods*; D017115:Catheter Ablation; D004562:Electrocardiography; D006329:Heart Conduction System / Q000503:physiopathology; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000150:complications / Q000503:physiopathology*; D011446:Prospective Studies; D017180:Tachycardia, Ventricular / Q000209:etiology / Q000503:physiopathology* / Q000601:surgery
Biometrics. 1986 Mar;42(1):121-30
3719049
Circulation. 1998 Sep 15;98 (11):1116-24
9736599
Circulation. 2000 Mar 21;101(11):1288-96
10725289
Am J Cardiol. 1986 Mar 1;57(8):582-6
3953443
J Am Coll Cardiol. 1991 Oct;18(4):1005-14
1894846
Circ Res. 1991 Feb;68(2):513-30
1991354
Circulation. 1998 Nov 10;98(19):2055-64
9808605
Circulation. 1988 Mar;77(3):589-606
3342490
J Am Coll Cardiol. 1990 Feb;15(2):393-401
2299082
Circulation. 1997 Sep 16;96(6):2016-21
9323094
Circulation. 1992 Dec;86(6):1872-87
1451259
Nat Med. 1996 Dec;2(12):1393-5
8946843
Circulation. 1999 Oct 19;100(16):1744-50
10525495
Circulation. 2002 Sep 24;106(13):1678-83
12270862
Circulation. 1993 Sep;88(3):915-26
8353918
Pacing Clin Electrophysiol. 1990 Jan;13(1):69-77
1689037
Circulation. 1986 Apr;73(4):693-700
3753909